Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > So anything good coming out soon

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Apr 06, 2022 5:03pm

123 Views

Post# 34582132

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:So anything good coming out soon

Maybe, but I would say it is not the most likely scenario. This is, after all, just a phase 1a test result and the number of patients that had a qualifying tumor is going to be pretty small. The stock price would need to surpass $5 to start breathing easier on that front so we would need it to double or more and maintain that price. With an offering likely coming up at some point soon and the help of the underwriters pumping up the share price for a while around that, that is possible, especially since TH's stock is already entering this period of potenital good news and increased attention via underwriters at a stupidly low level. So there is room for a lot of improvement but I will believe it when I see it. Moreover, I would like to see the share price in double digits rather than just be above $5 per share.

Re the part of my post that somehow got cut off, I was saying that TH needs to take many s teps to improve its share price and a reverse split announced on the back of good news is just one of those steps. It would not solve the market cap problem but it would allow for there to be more buyers than previously and would lower the need for current holders to sell to avoid regulatory and complliance (and insurance I might add) backlash.

palinc2000 wrote: Dont you think that good cancer news will /would propel the depressed SP to a level that would remove whatever regulatory concerns you may have.....

SPCEO1 wrote: Obviously, a part of the first paragraph in my post below got cut off somehow. Don't have time at the moment to recreate it - sorry.

SPCEO1 wrote: have a positive impact on the market cap eventually.

Ultimately, the biggest mover for the stock will be good data and wise financing decisions that put TH in the sight of investors who currently are not paying any attention to it at all. But there is no reason not to try and optimize the situation by doing a reverse stock split tied to good cancer news.

Biobob wrote: I'm far from convinced that if they reverse split the stock that large institutions will come... it's like the saying.. Built it and they will come... in Montreal they are building a public transport network with no user demand... billions wasted and garanteed annual gigantic deficits for the taxtapers.. another election promise on the back of taxpayers... just an example.